What’s happening to generic drug prices? April 2019 NADAC Survey Update

It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” It looks like we saw a lot of price decreases this past month, and and overall decrease in annualized spending. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates, plus an updated and upgraded NADAC Packed Bubble Chart!

Ben LinkMay 1, 2019NADAC, Medicaid, Anafranil, Clomipramine, Verelan, Kremers, Mylan, Verapamil, Symmetrel, Amantadine, California, Texas, Glumetza, Metformin